Patents Assigned to Empiriko Corporation
  • Ex vivo methods for predicting and confirming in vivo metabolism of pharmaceutically active compounds
    Patent number: 10265692
    Abstract: Methods and compositions for the catalytic oxidation of pharmaceutically active compounds, and more particularly to ex vivo methods for predicting in vivo metabolism of pharmaceutically active compounds, including predicting in vivo interaction between two or more pharmaceutically active compounds.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: April 23, 2019
    Assignee: Empiriko Corporation
    Inventors: Mukund Chorghade, Chiara Chapman